Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phenolsulphonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.57 |
| ▸ | PKLR | P30613 | 4/20 | 0.48 |
| ▸ | DUSP5 | Q16690 | 1/20 | 0.44 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | PGAM1 | P18669 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenolsulphonic Acid SCHEMBL3170291 | 0.98 | PTGS1 (0.55) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL3173341 | 0.98 | PTGS1 (0.55) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL3176513 | 0.95 | PTGS1 (0.52) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL237346 | 0.95 | PTGS1 (0.52) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL2967983 | 0.95 | PTGS1 (0.52) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL1394635 | 0.95 | PTGS1 (0.52) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL5404273 | 0.95 | PTGS1 (0.52) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL158699 | 0.95 | PKLR (0.53) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL20534105 | 0.95 | PTGS1 (0.52) | PTGS1PKLRDUSP5NR4A1CDK2 | |
| Phenolsulphonic Acid SCHEMBL1857993 | 0.95 | PTGS1 (0.52) | PTGS1PKLRDUSP5NR4A1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117185738-A | Building solid waste recycled concrete and processing technology thereof | 山西熙在高新材料有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-110041890-A | Compound dust suppressant of biology base and preparation method thereof | 中国葛洲坝集团易普力股份有限公司 | 2019-07-23 | — | — | CN | claimed |
| CN-105420736-B | A kind of vinyl chloride converter high-temperature corrosion inhibitor and its preparation and application | 常州中南化工有限公司 | 2018-09-07 | — | — | CN | claimed |
| CN-108042381-A | Paeonol derivative is in skin anti-inflammatory, anti-acne, whitening, nti-freckle and the application in dispelling pigmentation | 陕西医药控股医药研究院有限公司 | 2018-05-18 | — | — | CN | claimed |
| EP-2031008-B1 | REACTION ACCELERATOR FOR CONDUCTIVE POLYMER SYNTHESIS, CONDUCTIVE POLYMER AND SOLID ELECTROLYTIC CAPACITOR | TAYCA CORP (JP) | 2016-10-05 | — | — | EP | claimed |
| CN-105796513-A | Calcium dobesilate pharmaceutical composition | 江苏万邦生化医药股份有限公司 | 2016-07-27 | — | — | CN | claimed |
| CN-105418466-A | Calcium dobesilate compound and preparation method thereof | SHIJIAZHUANG HUAXIN PHARMACEUTICAL CO LTD | 2016-03-23 | — | — | CN | claimed |
| CN-102112000-B | Anti-allergen combinations of calcium and lanthanum salts | JANSSEN PHARMACEUTICA NV | 2015-02-25 | — | — | CN | claimed |
| CN-103877038-A | Calcium dobesilate dispersible tablet and preparation method thereof | JIANGSU WANBANG BIOPHARMACEUTICALS CO LTD | 2014-06-25 | — | — | CN | claimed |
| US-20130280199-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE HYGROSCOPIC SALT, AT LEAST ONE AROMATIC POLYOL ETHER AND AT LEAST ONE DIOL, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2013-10-24 | — | — | US | claimed |
| US-20110135750-A1 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM | BYLEMANS DANY LEOPOLD JOZEFIEN | 2011-06-09 | — | — | US | claimed |
| EP-2323485-A1 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM SALTS | Janssen Pharmaceutica, N.V. (BE) | 2011-05-25 | — | — | EP | claimed |
| CN-101880248-A | Synthetic reaction of calcium dobesilate hydrate | NINGXIA KANGYA PHARMACEUTICAL CO LTD | 2010-11-10 | — | — | CN | claimed |
| WO-2010015697-A1 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM SALTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-02-11 | — | — | WO | claimed |
| US-7651639-B2 | Conductive polymer and solid electrolytic capacitor using the same | TAYCA CORPORATION (JP) | 2010-01-26 | — | — | US | claimed |
| CN-1259042-C | Calcium phenol sulfonate dispersive tablets and their preparation | XU XINSHENG (CN) | 2006-06-14 | — | — | CN | claimed |
| CN-1214002-C | Process for synthesizing hydrate of calcium phenolsulfonate | LIJUN PHARMACEUTICAL CO LTD XI (CN) | 2005-08-10 | — | — | CN | claimed |
| CN-1582910-A | Calcium phenol sulfonate dispersive tablets and their preparation | XU XINSHENG (CN) | 2005-02-23 | — | — | CN | claimed |
| CN-1359897-A | Process for synthesizing hydrate of calcium phenolsulfonate | LIJUN PHARMACEUTICAL CO LTD XI (CN) | 2002-07-24 | — | — | CN | claimed |
| US-6071417-A | ADDITION OF ALKALI POLYPHOSPHATES TO AN AQUEOUS SOLUTION CONTAINING RESIDUAL AMOUNTS OF CATIONIC, ANIONIC, OR AMPHOTERIC WATER-SOLUBLE MACROMOLECULAR COMPOUNDS, FORMATION OF INSOLUBLE COMPLEXES OF THE ALKALI POLYPHOSPHATE | KURITA WATER INDUSTRIES, LTD. (JP) | 2000-06-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130280199-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE HYGROSCOPIC SALT, AT LEAST ONE AROMATIC POLYOL ETHER AND AT LEAST ONE DIOL, AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, H1-0 | PTGS1 3955/4885PKLR 628/4885DUSP5 2155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.